Literature DB >> 22137109

Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naïve patients and the general Japanese population.

Akiko Ozaki1, Yuichi Inoue, Kenichi Hayashida, Toru Nakajima, Makoto Honda, Akira Usui, Yoko Komada, Mina Kobayashi, Kiyohisa Takahashi.   

Abstract

OBJECTIVE: To assess the quality of life of patients with narcolepsy with cataplexy (NA-CA), narcolepsy without cataplexy (NA w/o CA), and idiopathic hypersomnia without long sleep time (IHS w/o LST) who were taking psychostimulant medication, and to ascertain which factors (including psychosocial and environmental variables) influence quality of life in this population.
METHODS: In total, 185 patients who had received regular treatment were enrolled in the study (NA-CA, n=83; NA w/o CA, n=48; IHS w/o LST, n=54). Patients were asked to complete questionnaires including the Short Form-36 Health Survey (SF-36), the Epworth Sleepiness Scale (ESS), and items concerning psychosocial and environmental variables.
RESULTS: All three diagnostic groups had significantly lower scores for most SF-36 domains compared with the Japanese normative data, and the ESS score was significantly reduced with treatment. Multiple logistic regression analyses revealed that several SF-36 domains were associated with the ESS score; autonomy in controlling own job schedule, experience of divorce or break up with a partner due to symptoms, experience of being forced to relocate or being dismissed due to symptoms, and perception of support from others.
CONCLUSIONS: The severity of subjective sleepiness and psychological and environmental variables influenced quality of life in patients with these hypersomnias of central origin.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22137109     DOI: 10.1016/j.sleep.2011.07.014

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  19 in total

Review 1.  Idiopathic Hypersomnia.

Authors:  Lynn Marie Trotti
Journal:  Sleep Med Clin       Date:  2017-06-16

2.  Quality measures for the care of patients with narcolepsy.

Authors:  Lois E Krahn; Shelley Hershner; Lauren D Loeding; Kiran P Maski; Daniel I Rifkin; Bernardo Selim; Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

3.  Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.

Authors:  Maeve Pascoe; James Bena; Nancy Foldvary-Schaefer
Journal:  J Clin Sleep Med       Date:  2019-10-30       Impact factor: 4.062

4.  Diagnosis and management of central hypersomnias.

Authors:  Karel Sonka; Marek Susta
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

5.  The Humanistic and Economic Burden of Narcolepsy.

Authors:  Natalia M Flores; Kathleen F Villa; Jed Black; Ronald D Chervin; Edward A Witt
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

6.  Another Strike Against Sleepability.

Authors:  Lynn Marie Trotti
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

Review 7.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

8.  Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Donald L Bliwise; Amanda A Freeman; Andrew Jenkins; David B Rye
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

9.  Factors associated with duration before receiving definitive diagnosis of narcolepsy among Japanese patients affected with the disorder.

Authors:  Yoichiro Ueki; Kenichi Hayashida; Yoko Komada; Masaki Nakamura; Mina Kobayashi; Makio Iimori; Yuichi Inoue
Journal:  Int J Behav Med       Date:  2014-12

10.  The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study.

Authors:  Chad Ruoff; Fabio Pizza; Lynn Marie Trotti; Karel Sonka; Stefano Vandi; Joseph Cheung; Swaroop Pinto; Mali Einen; Narong Simakajornboon; Fang Han; Paul Peppard; Sona Nevsimalova; Giuseppe Plazzi; David Rye; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.